In silico identification and experimental validation of cellular uptake by a new cell penetrating peptide P1 derived from MARCKS

Viral vectors for vaccine delivery are challenged by recently reported safety issues like immunogenicity and risk for cancer development, and thus there is a growing need for the development of non-viral vectors. Cell penetrating peptides (CPPs) are non-viral vectors that can enter plasma membranes...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Linlin, Guo, Xiangli, Wang, Lidan, Geng, Jingping, Wu, Jiao, Hu, Bin, Wang, Tao, Li, Jason, Liu, Changbai, Wang, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330795/
https://www.ncbi.nlm.nih.gov/pubmed/34338123
http://dx.doi.org/10.1080/10717544.2021.1960922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330795/
https://www.ncbi.nlm.nih.gov/pubmed/34338123
http://dx.doi.org/10.1080/10717544.2021.1960922

Ejemplares similares